0000899140-23-000672.txt : 20230519
0000899140-23-000672.hdr.sgml : 20230519
20230519211219
ACCESSION NUMBER: 0000899140-23-000672
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230517
FILED AS OF DATE: 20230519
DATE AS OF CHANGE: 20230519
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DENNER ALEXANDER J
CENTRAL INDEX KEY: 0001361754
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30319
FILM NUMBER: 23942224
MAIL ADDRESS:
STREET 1: C/O SARISSA CAPITAL MANAGEMENT LP
STREET 2: 660 STEAMBOAT ROAD, 3RD FLOOR
CITY: GREENWICH
STATE: CT
ZIP: 06830
FORMER NAME:
FORMER CONFORMED NAME: Denner Alexander J
DATE OF NAME CHANGE: 20060504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sarissa Capital Management LP
CENTRAL INDEX KEY: 0001577524
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30319
FILM NUMBER: 23942223
BUSINESS ADDRESS:
STREET 1: 660 STEAMBOAT ROAD
CITY: GREENWICH
STATE: CT
ZIP: 06830
BUSINESS PHONE: 203-302-2330
MAIL ADDRESS:
STREET 1: 660 STEAMBOAT ROAD
CITY: GREENWICH
STATE: CT
ZIP: 06830
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Innoviva, Inc.
CENTRAL INDEX KEY: 0001080014
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943265960
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1350 OLD BAYSHORE HIGHWAY
STREET 2: SUITE 400
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 6502389600
MAIL ADDRESS:
STREET 1: 1350 OLD BAYSHORE HIGHWAY
STREET 2: SUITE 400
CITY: BURLINGAME
STATE: CA
ZIP: 94010
FORMER COMPANY:
FORMER CONFORMED NAME: THERAVANCE INC
DATE OF NAME CHANGE: 20020207
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MEDICINE INC
DATE OF NAME CHANGE: 20000302
4/A
1
form4.xml
X0407
4/A
2023-05-17
2023-05-19
0001080014
Innoviva, Inc.
INVA
0001361754
DENNER ALEXANDER J
C/O SARISSA CAPITAL MANAGEMENT LP
680 STEAMBOAT ROAD
GREENWICH
CT
06830
true
0001577524
Sarissa Capital Management LP
680 STEAMBOAT ROAD
GREENWICH
CT
06830
true
false
Common Stock, par value $0.01 per share
2023-05-17
4
P
0
50000
13.0738
A
6954000
I
See footnotes
Common Stock, par value $0.01 per share
2023-05-18
4
P
0
10000
13.0538
A
6964000
I
See footnotes
Common Stock, par value $0.01 per share
2023-05-19
4
P
0
36000
13.4763
A
7000000
I
See footnotes
On May 17, 2023, the Reporting Persons acquired 50,000 shares of Common Stock at a weighted average price of $13.0738 per share. The shares were purchased in multiple open market transactions at prices ranging from $13.00 to $13.13 per share, inclusive. The Reporting Persons undertake to provide, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
On May 18, 2023, the Reporting Persons acquired 10,000 shares of Common Stock at a weighted average price of $13.0538 per share. The shares were purchased in multiple open market transactions at prices ranging from $13.01 to $13.07 per share, inclusive. The Reporting Persons undertake to provide, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
On May 19, 2023, the Reporting Persons acquired 36,000 shares of Common Stock at a weighted average price of $13.4763 per share. The shares were purchased in multiple open market transactions at prices ranging from $13.47 to $13.49 per share, inclusive. The Reporting Persons undertake to provide, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
Sarissa Capital Management LP ("Sarissa Capital") is the investment advisor to Sarissa Capital Offshore Master Fund LP, Sarissa Capital Catapult Fund LLC, Sarissa Capital Hawkeye Fund LP and Sarissa Capital Master Fund II LP (collectively, the "Sarissa Funds") and may be deemed to beneficially own the shares of Common Stock directly beneficially owned by the Sarissa Funds by virtue of the authority granted to it to vote and to dispose of the securities held by them, including the shares of Common Stock. Alexander J. Denner, Ph.D., a citizen of the United States of America ("Dr. Denner"), is the Chief Investment Officer and ultimate general partner of Sarissa Capital and is the ultimate general partner, or controls the managing member, of each of the Sarissa Funds; accordingly, Dr. Denner may be deemed to beneficially own the shares of Common Stock directly held by the Sarissa Funds by virtue of such positions.
Each of Dr. Denner, Sarissa Capital and each of the Sarissa Funds disclaims beneficial ownership of the shares of Common Stock reported herein except, in each case, to the extent of their pecuniary interest therein
SARISSA CAPITAL MANAGEMENT LP; By: /s/ Mark DiPaolo, Senior Partner, General Counsel
2023-05-19
/s/ Alexander J. Denner
2023-05-19